AUTL
Autolus Therapeutics plc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
No N-PORT holders.
—
—
No thesis.
Expected move
No implied move.
Linked news
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | MAK Capital OneMAK Capital One | $53.8M | 25.32% | 0.00% | |
| 2 | Blackstone GroupBlackstone | $32.8M | 15.43% | new | |
| 3 | Syncona PortfolioSyncona Portfolio | $26.6M | 12.53% | 0.00% | |
| 4 | Armistice CapitalArmistice Capital | $24.0M | 11.30% | −5.06% | |
| 5 | Polygon ManagementPolygon | $15.2M | 7.15% | 0.00% | |
| 6 | Schroder Investment Management GroupSchroder | $12.9M | 6.08% | −17.45% | |
| 7 | Frazier Life Sciences ManagementFrazier Life Sciences | $7.1M | 3.35% | 0.00% | |
| 8 | BNP Paribas Investment PartnersBNP Paribas Investment Partners | $5.4M | 2.53% | 0.00% | |
| 9 | Laurion Capital ManagementLaurion | $5.3M | 2.50% | 0.00% | |
| 10 | Renaissance TechnologiesRenaissance Technologies | $3.2M | 1.49% | −13.69% | |
| 11 | Bank of AmericaBank of America | $2.6M | 1.21% | −12.99% | |
| 12 | BlackRockBlackRockindex-like | $2.6M | 1.21% | +8.29% | |
| 13 | UBS GroupUBS | $2.4M | 1.14% | +16.18% | |
| 14 | Morgan StanleyMorgan Stanley | $2.0M | 0.95% | +33.87% | |
| 15 | Millennium ManagementMillennium | $2.0M | 0.92% | +498.27% | |
| 16 | Cetera Investment AdvisersCetera Investment | $1.9M | 0.87% | +2.50% | |
| 17 | Balyasny Asset ManagementBalyasny | $1.6M | 0.73% | +0.11% | |
| 18 | JPMorgan ChaseJPMorgan Chase | $1.5M | 0.71% | new | |
| 19 | Citadel AdvisorsCitadel | $1.3M | 0.61% | +37.55% | |
| 20 | AlphabetAlphabet | $1.1M | 0.53% | 0.00% | |
| 21 | Jane Street GroupJane Street | $817,699 | 0.38% | +23.36% | |
| 22 | Hennion & Walsh Asset ManagementHennion & Walsh | $722,245 | 0.34% | +2.54% | |
| 23 | Privium Fund Management B.V.Privium Fund Management B.V. | $581,488 | 0.27% | 0.00% | |
| 24 | Edentree Asset ManagementEdentree | $477,000 | 0.22% | 0.00% | |
| 25 | XTX TopcoXTX Topco | $459,930 | 0.22% | +409.63% |
82 managers report $212.5M of Autolus Therapeutics on form 13F for the quarter ended Jun 30 '26. 7 of them hold 80% of it; MAK Capital One is largest at 25.32%.
Autolus Therapeutics plc
1.51